Smart science to improve lives™
Open search Basket 0 View basket

Explore our product offering by market:

We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications. 

scientist in lab looking at a slide

Human pharmaceuticals

We specialise in developing the highest quality and purest grades of pharmaceutical excipients, lipids and vaccine adjuvants to help you formulate seamlessly and drive your products to market. We tailor excipient purity to your needs. We are committed to product quality, regulatory excellence, and supply chain security. We have worked with many pharma companies to bring COVID-19 vaccines and treatments to market faster, using our adjuvant and Super Refined™ excipients. While continuing to invest in expanding our portfolio and manufacturing footprint globally, quality is at the forefront of our plans.
Cow and dog in field with blue wash over image

Veterinary health

To serve the growing veterinary health market, we develop and commercialise a wide range of specialty excipients which are used to enhance the delivery, efficacy, and stability of actives in livestock and companion animal health products. Our broad portfolio also comprises adjuvants for the important veterinary vaccine market and extends further to omega-3 essential fatty acids for pet food products. We collaborate with your formulation scientists to produce safer, more efficient, and highly specialised products that are used across a variety of marketed veterinary dosage forms. We strive to offer innovative solutions to meet the challenges formulators, veterinarians and livestock producers face every day.

How we empower biologics delivery

Image of Croda Pharma innovating in a lab

Enabling breakthrough innovation

Dedicated to developing the next generation of excipients and delivery systems to empower biopharma
Female Croda Pharma employee formulating in lab

Access to specialist formulation support

Enabling over 250 on-going clinical projects targeting a range of therapeutic areas across biologics and small molecules
Croda Pharma employee in a lab

Focused scientific expertise

Leading the way with specialist knowledge and synthesis expertise in excipients, adjuvants and lipids

Explore recent blogs:

Image of Thomas Reirmeier

Croda welcomes Thomas Riermeier as new President of Life Sciences

Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that Dr. Thomas Riermeier has been appointed as the new...
oncology webinar key learnings

From Lab to Patient: Optimising Oncology Formulations with Purified Excipients

In 2024, we hosted a live webinar exploring the impact of our Super RefinedTM excipients on various chemotherapeutic formulations. This blog will explore some of the key learnings from the webinar.
Certest Logo

Croda’s Avanti Research expands ionizable lipid offering for LNP drug development through Certest collaboration

Avanti Polar Lipids, LLC, a wholly owned subsidiary of Croda International Plc, and Certest Biotec S.L. (Certest) are pleased to announce a strategic collaboration to expand the market’s access to...